Elana Rosenthal, MD

BA, Yale University, 2006

MD, University of Chicago Pritzker School of Medicine, 2010

Residency - Internal Medicine, Beth Israel Deaconess Medical Center, 2013

Fellowship - Infectious Diseases, Beth Israel Deaconess Medical Center, 2015

I am a physician specializing in infectious diseases, and serve as co-director of the Research Initiative in Infectious Disease and Substance Use. My research and clinical care focus on the intersection of substance use disorder and infectious diseases, a focus on gender and sexual minorities, and incarcerated populations. I practice in community based sites in Washington, DC and Baltimore.

HCV, HIV, PWID

1. Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis. Am J Med. 2016 May;129(5):481-5. doi: 10.1016/j.amjmed.2015.09.024. Epub 2015 Nov 18. PMID: 26597670.
2. Rosenthal ES, Kottilil S, Polis MA. Sofosbuvir and ledipasvir for HIV/HCV co-infected patients.Expert Opin Pharmacother. 2016;17(5):743-9. doi: 10.1517/14656566.2016.1157580. Epub 2016 Mar 16. PMID: 26898158; PMCID: PMC4930150.
3. Rosenthal ES, Graham CS. Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States. Infect Agent Cancer. 2016 May 16;11:24. doi: 10.1186/s13027-016-0071-z. PMID: 27186235; PMCID: PMC4867525.
4. Theisen-Toupal J, Ronan MV, Moore A, Rosenthal ES. Inpatient Management of Opioid Use Disorder: A Review for Hospitalists. J Hosp Med. 2017 May;12(5):369-374. doi: 10.12788/jhm.2731. PMID: 28459909
5. Rosenthal ES, Kattakuzhy S, Kottilil S. Time to end treatment restrictions for people with hepatitis C who inject drugs. Lancet Gastroenterol Hepatol. 2018 Jan 5. pii: S2468-1253(18)30001-3. doi: 10.1016/S2468-1253(18)30001-3. [Epub ahead of print] PMID: 29310927
6. Kattakuzhy S, Gross C, Emmanuel B, Teferi G, Jenkins V, Silk R, Akoth E, Thomas A, Ahmed C, Espinosa M, Price A, Rosenthal E, Tang L, Wilson E, Bentzen S, Masur H, Kottilil S; ASCEND Providers. Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial. Ann Intern Med. 2017 Sep 5;167(5):311-318. doi: 10.7326/M17-0118. Epub 2017 Aug 8. PMID: 28785771; PMCID: PMC5736381.
7. Schwetz T, Calder T, Rosenthal E, Kattakuzhy S, Fauci AF. Opioids and Infectious Diseases: A Converging Public Health Crisis. Journal of Infectious Diseases. 2019 Jul 2;220(3):346-349. doi: 10.1093/infdis/jiz133.
8. Wilson E, Covert E, Hoffman J, Comstock E, Emmanuel B, Tang L, Husson J, Chua J, Price A, Mathur P, Rosenthal E, Kattakuzhy S, Masur H, Kottilil S. A Pilot Study of Safety and Efficacy of HCV Retreatment with SOF/VEL/VOX in Patients With or Without HIV (RESOLVE Study). Journal of Hepatology. 2019 Sep;71(3):498-504. doi: 10.1016/j.jhep.2019.05.021.
9. Rosenthal ES, Silk R, Mathur P, Gross C, Eyasu R, Nussdorf L, Hill K, Brokus C, D'Amore A, Sidique N, Bijole P, Jones M, Kier R, McCullough D, Sternberg D, Stafford K, Sun J, Masur H, Kottilil S, Kattakuzhy S. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs. Clin Infect Dis. 2020 Oct 23;71(7):1715-1722. doi: 10.1093/cid/ciaa105. PMID: 32009165; PMCID: PMC7755091.
10. Li A, Rosenthal ES, Rapoport AB, Rowley CF. Opioid use disorder and infectious complications in persons who inject drugs. Int Anesthesiol Clin. 2020 Spring;58(2):4-11. doi: 10.1097/AIA.0000000000000276. PMID: 32073421.
11. Kattakuzhy S, Rosenthal E. To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug-user Health. Clin Infect Dis. 2021 Jul 1;73(1):e119-e121. doi: 10.1093/cid/ciaa607. PMID: 32445562.
12. Hill K, Nussdorf L, Mount JD, Silk R, Gross C, Sternberg D, Bijole P, Jones M, Kier R, Mccullough D, Mathur P, Kottilil S, Masur H, Kattakuzhy S, Rosenthal ES. Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. J Addict Med. 2022 Jan-Feb 01;16(1):10-17. doi: 10.1097/ADM.0000000000000807. PMID: 33560694; PMCID: PMC8923533.
13. Kattakuzhy S, Rosenthal E. Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care. J Addict Med. 2021 Nov-Dec 01;15(6):452-453. doi: 10.1097/ADM.0000000000000802. PMID: 34734571.
14. Brokus C, Kattakuzhy S, Gayle B, Narayanan S, Davis A, Cover A, Eyasu R, Ebah E, Ogbumbadiugha-Weekes O, Hoffmann J, Silk R, Stevens J, Mount J, Gannon C, Nussdorf L, Mathur P, Bijole P, Jones M, Kier R, Sternberg D, Greenblatt A, Weintraub E, Masur H, Kottilil S, Rosenthal E. Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment. Open Forum Infect Dis. 2021 Dec 29;9(3):ofab658. doi: 10.1093/ofid/ofab658. PMID: 35187191; PMCID: PMC8849288.
15. Hill KC, Kattakuzhy SM, Silk R, Eyasu R, Ogbumbadiugha O, Ebah E, Cover AA, Davis A, Gayle B, Sternberg D, Bijole P, Sun J, Masur H, Kottilil S, Solomon D, Rosenthal ES. PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV. Open Forum Infect Dis. 2022 Sep 14;9(10):ofac476. doi: 10.1093/ofid/ofac476. PMID: 36225745; PMCID: PMC9547499.
16. Spaderna M, Kattakuzhy S, Kang SJ, George N, Bijole P, Ebah E, Eyasu R, Ogbumbadiugha O, Silk R, Gannon C, Davis A, Cover A, Gayle B, Narayanan S, Pao M, Kottilil S, Rosenthal E. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. Int J Drug Policy. 2023 Jan;111:103906. doi: 10.1016/j.drugpo.2022.103906. Epub 2022 Nov 13. PMID: 36384062; PMCID: PMC9868066.
17. Carpenter JE, Catalanotti J, Notis M, Brokus C, Moran TP, Akselrod H, Burkholder G, Eaton EF, Kuo I, Mai W, McGonigle K, Steck A, Del Rio C, Saag M, Kottilil S, Masur H, Kattakuzhy S, Rosenthal ES. Use of nonstigmatizing language is associated with improved outcomes in hospitalized people who inject drugs. J Hosp Med. 2023 Jun 7. doi: 10.1002/jhm.13146. Epub ahead of print. PMID: 37286190.
18. Rosenthal ES, Brokus C, Sun J, Carpenter JE, Catalanotti J, Eaton EF, Steck AR, Kuo I, Burkholder GA, Akselrod H, Mcgonigle K, Moran T, Mai W, Notis M, Del Rio C, Greenberg A, Saag MS, Kottilil S, Masur H, Kattakuzhy S. Undertreatment of opioid use disorder in patients hospitalized with injection drug use associated infections. AIDS. 2023 Jun 21. doi: 10.1097/QAD.0000000000003629. Epub ahead of print. PMID: 37352497.